[HTML][HTML] Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma—a contemporary systematic review

FA Rashid, J Munkhdelger, J Fukuoka, A Bychkov - Gland Surgery, 2020 - ncbi.nlm.nih.gov
Papillary thyroid carcinoma (PTC), the most common malignancy of the endocrine system, is
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …

[HTML][HTML] Correlations between molecular landscape and sonographic image of different variants of papillary thyroid carcinoma

A Lewiński, Z Adamczewski, A Zygmunt… - Journal of clinical …, 2019 - mdpi.com
Papillary thyroid carcinoma (PTC), the most common thyroid cancer, is predominantly driven
by mutations in BRAF (primarily p. V600E) and RAS oncogenes. Ultrasound (US) …

Radiomics study of thyroid ultrasound for predicting BRAF mutation in papillary thyroid carcinoma: preliminary results

MR Kwon, JH Shin, H Park, H Cho… - American Journal of …, 2020 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: It is not known how radiomics using ultrasound images
contribute to the detection of BRAF mutation. This study aimed to evaluate whether a …

[HTML][HTML] Radiomic Model for Determining the Value of Elasticity and Grayscale Ultrasound Diagnoses for Predicting BRAFV600E Mutations in Papillary Thyroid …

Y Wang, F Xu, EA Agyekum, H Xiang, Y Wang… - Frontiers in …, 2022 - frontiersin.org
BRAFV600E is the most common mutated gene in thyroid cancer and is most closely related
to papillary thyroid carcinoma (PTC). We investigated the value of elasticity and grayscale …

MRI-based texture analysis for preoperative prediction of BRAF V600E mutation in papillary thyroid carcinoma

T Zheng, W Hu, H Wang, X Xie, L Tang… - Journal of …, 2023 - Taylor & Francis
Purpose BRAF V600E mutation can compensate for the low detection rate by fine-needle
aspiration (FNA) and is related to aggressiveness and lymph node metastasis. This study …

[HTML][HTML] Association analysis and the clinical significance of BRAF gene mutations and ultrasound features in papillary thyroid carcinoma

Y Liu, L He, G Yin, L Cheng, B Zeng… - Oncology …, 2019 - spandidos-publications.com
The aim of the present study was to evaluate the associations between the B‑Raf proto‑
oncogene serine/threonine kinase (BRAF) V600E mutation and conventional and contrast …

[HTML][HTML] Construction and validation of BRAF mutation diagnostic model based on ultrasound examination and clinical features of patients with thyroid nodules

C Xu, J Fang, W Li, C Sun, Y Li, S Lowe… - Frontiers in …, 2022 - frontiersin.org
Introduction: Fine Needle Aspiration (FNA) is currently the most popular method for
identifying benign and malignant thyroid nodules. However, its diagnostic sensitivity is …

[HTML][HTML] BRAF V600E 基因检测联合细针穿刺活检对甲状腺结节良恶性诊断中的价值

卢振启, 龚文博, 黑虎, 秦建武 - 中国肿瘤临床, 2019 - cjco.cn
BRAF V600E基因检测联合细针穿刺活检对甲状腺结节良恶性诊断中的价值 首页 期刊简介 1.期刊
介绍 2.获奖情况 编委会 期刊在线 1.最新录用 2.优先发表 3.当期目录 4.过刊浏览 视频合辑 在线 …

[HTML][HTML] Nuclear interaction of Arp2/3 complex and BRAFV600E promotes aggressive behavior and vemurafenib resistance of thyroid cancer

M Zerfaoui, K Tsumagari, E Toraih… - American Journal of …, 2022 - ncbi.nlm.nih.gov
The presence of mutant BRAF V600E correlates with the risk of recurrence in papillary
thyroid cancer (PTC) patients. However, not all PTC patients with BRAF V600E are …

[PDF][PDF] BRAF-V600E 突变检测在B 超引导下甲状腺细针穿刺标本中的应用及意义

李晓锋, 刘希, 汪园园, 隋艳霞, 张冠军 - 临床与病理杂志, 2020 - cdn.amegroups.cn
目的: 探讨BRAF-V600E 突变对甲状腺良恶性结节鉴别的临床意义. 方法: 选取2019 年1 至4
月180 例患者(192 个) 甲状腺结节细针穿刺样本进行BRAF-V600E 基因突变检测, 将BRAF …